+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes



Simultaneous pancreas kidney transplant versus other kidney transplant options in patients with type 2 diabetes



Clinical Journal of the American Society of Nephrology 7(4): 656-664



Current organ allocation policy prioritizes placement of kidneys (with pancreas) to patients listed for simultaneous pancreas-kidney transplantation (SPK). Patients with type 2 diabetes mellitus (T2DM) may undergo SPK, but it is unknown whether these patients enjoy a survival advantage with SPK versus deceased-donor kidney transplantation alone (DDKA) or living-donor kidney transplantation alone (LDKA). Using the Scientific Registry of Transplant Recipients database, patients with T2DM, age 18-59 years, body mass index 18-30 kg/m(2), who underwent SPK, DDKA, or LDKA from 2000 through 2008 were identified. Five-year patient and kidney graft survival rates were compared, and multivariable analysis was performed to determine donor, recipient, and transplant factors influencing these outcomes. Of 6416 patients identified, 4005, 1987, and 424 underwent DDKA, LDKA, and SPK, respectively. On unadjusted analysis, patient and kidney graft survival rates were superior for LDKA versus SPK, whereas patient but not graft survival was higher for SPK versus DDKA. On multivariable analysis, survival advantage for SPK versus DDKA was related not to pancreas transplantation but younger donor and recipient ages in the SPK cohort. Good outcomes can occur with SPK in selected patients with T2DM, but no patient or graft survival advantage is provided by added pancreas transplantation compared with DDKA; outcomes were superior with LDKA. These results support cautious use of SPK in T2DM when LDKA is not an option, with close oversight of the effect of kidney (with pancreas) allocation priority over other transplant candidates.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055790630

Download citation: RISBibTeXText

PMID: 22344508

DOI: 10.2215/cjn.08310811


Related references

Pancreas transplant options for patients with type 1 diabetes mellitus and chronic kidney disease: simultaneous pancreas kidney or pancreas after kidney?. Current Opinion in Organ Transplantation 17(1): 80-86, 2012

Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. British Journal of Surgery 90(9): 1137-1141, 2003

Renal allograft survival and morbidity in simultaneous pancreas kidney spk transplant versus kidney transplant alone kta in diabetic patients pts. Journal of the American Society of Nephrology 2(3): 794, 1991

Cardiovascular benefits of simultaneous pancreas-kidney transplant versus kidney alone transplant in diabetic patients. Transplantation Proceedings 37(8): 3570-3571, 2005

Simultaneous pancreas-kidney transplant compared with kidney transplant in type I diabetic patients with end-stage renal disease. Transplantation Proceedings 34(1): 204-205, 2002

Simultaneous pancreas-kidney transplant compared with kidney transplant in Type I diabetic patients with end-stage renal disease. Transplantation Proceedings 33(7-8): 3494-3495, 2001

Simultaneous pancreas-kidney transplant versus kidney transplant alone in diabetic patients. Kidney International 41(4): 924-929, 1992

Should uremic diabetic patients who want a pancreas transplant receive a simultaneous cadaver kidney-pancreas transplant or a living related donor kidney first followed by cadaver pancreas transplant?. Transplantation Proceedings 25(1 Pt 2): 1184-1185, 1993

The impact of pre-transplant dialysis on simultaneous pancreas-kidney versus living donor kidney transplant outcomes. Nephrology Dialysis Transplantation 28(4): 1047-1058, 2013

There are no differences in pretransplant characteristics of individuals receiving simultaneous pancreas-kidney transplant and individuals with type 1 diabetes mellitus receiving living-related kidney transplant. Transplantation Proceedings 36(4): 1084-1085, 2004

Living donor kidney versus simultaneous pancreas-kidney transplant in type I diabetics: an analysis of the OPTN/UNOS database. Clinical Journal of the American Society of Nephrology 4(4): 845-852, 2009

Simultaneous Pancreas and Kidney Transplantation-Is It a Treatment Option for Patients With Type 2 Diabetes Mellitus? An Analysis of the International Pancreas Transplant Registry. Current Diabetes Reports 17(6): 44, 2017

An analysis of the survival outcomes of simultaneous pancreas and kidney transplantation compared to live donor kidney transplantation in patients with type 1 diabetes: a UK Transplant Registry study. Transplant International 30(9): 884-892, 2017

Retransplantation of the pancreas in a patient with type 1 diabetes (T1D) following simultaneous pancreas-kidney (SPK) transplantation and recurrence of type I diabetes (T1DR): The role of peri-pancreas transplant lymph nodes. 2007

Pancreas after living donor kidney versus simultaneous pancreas-kidney transplant: an analysis of the organ procurement transplant network/united network of organ sharing database. Transplantation 89(12): 1496-1503, 2010